BeiGene (HKSE:06160) Days Sales Outstanding : 48.03 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is BeiGene Days Sales Outstanding?

BeiGene's average Accounts Receivable for the three months ended in Dec. 2023 was HK$2,608 Mil. BeiGene's Revenue for the three months ended in Dec. 2023 was HK$4,955 Mil. Hence, BeiGene's Days Sales Outstanding for the three months ended in Dec. 2023 was 48.03.

The historical rank and industry rank for BeiGene's Days Sales Outstanding or its related term are showing as below:

HKSE:06160' s Days Sales Outstanding Range Over the Past 10 Years
Min: 39.43 Med: 64.89 Max: 84.59
Current: 43.03

During the past 11 years, BeiGene's highest Days Sales Outstanding was 84.59. The lowest was 39.43. And the median was 64.89.

HKSE:06160's Days Sales Outstanding is ranked better than
74.33% of 892 companies
in the Biotechnology industry
Industry Median: 72.19 vs HKSE:06160: 43.03

BeiGene's Days Sales Outstanding increased from Dec. 2022 (43.68) to Dec. 2023 (48.03).

BeiGene Days Sales Outstanding Historical Data

The historical data trend for BeiGene's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BeiGene Days Sales Outstanding Chart

BeiGene Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

47.74

77.85

84.27

84.70

39.39

BeiGene Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															43.68	49.05	46.72	35.54	48.03

Competitive Comparison of BeiGene's Days Sales Outstanding

For the Biotechnology subindustry, BeiGene's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BeiGene's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BeiGene's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where BeiGene's Days Sales Outstanding falls into.

BeiGene Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

BeiGene's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (1348.182	+	2796.119)	/	2 )	/	19202.572	*	365
=	2072.1505					/	19202.572	*	365
=	39.39

BeiGene's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (2419.625	+	2796.119)	/	2 )	/	4954.607	*	365 / 4
=	2607.872					/	4954.607	*	365 / 4
=	48.03

BeiGene (HKSE:06160) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

BeiGene Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of BeiGene's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

BeiGene (HKSE:06160) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BeiGene Ltd (HKSE:06160) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

BGNE:USA 49BA:Germany 688235:China B1GN34:Brazil

Address

c/o Mourant Governance Services (Cayman) Limited, 94 Solaris Avenue, Camana Bay, Grand Cayman, CYM, KY1-1108

Website

https://www.beigene.com

BeiGene Ltd is a commercial-stage biotechnology company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. It has developed clinical-stage drug candidates that inhibit the important oncology targets Bruton's tyrosine kinase, or BTK; RAF dimer protein complex and PARP family of proteins, and an immuno-oncology agent that inhibits the immune checkpoint protein receptor PD-1. Its geographical segments are China, the United States, and the Rest of the world.

BeiGene (HKSE:06160) Headlines

No Headlines